Adjuvant 131I-metuximab for hepatocellular carcinoma after liver resection: a randomised, controlled, multicentre, open-label, phase 2 trial-Reference-Cited by-同舟云学术

Adjuvant 131I-metuximab for hepatocellular carcinoma after liver resection: a randomised, controlled, multicentre, open-label, phase 2 trial

Published:2020-06 Issue:6 Volume:5 Page:548-560
ISSN:2468-1253
Container-title:The Lancet Gastroenterology & Hepatology
language:en
Short-container-title:The Lancet Gastroenterology & Hepatology

Author:

Li Jun,Xing Jingliang,Yang Yefa,Liu Jingfeng,Wang Wentao,Xia Yong,Yan Zhenlin,Wang Kui,Wu Dong,Wu Lu,Wan Xuying,Yang Tian,Gao Chunfang,Si Anfeng,Wang Hongyang,Wu Mengchao,Lau Wan Yee,Chen Zhinan,Shen Feng

Funder

State Key Project on Infectious Diseases of China

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference30 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J Clin,2018

2. Hepatocellular carcinoma;Forner;Lancet,2018

3. Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma;Poon;Cancer,2000

4. Early and late recurrence after liver resection for hepatocellular carcinoma: prognostic and therapeutic implications;Portolani;Ann Surg,2006

5. Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update;Omata;Hepatol Int,2017

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development and validation of a novel immune‒metabolic-Based classifier for hepatocellular carcinoma;Heliyon;2024-09

2. The trajectory of vesicular proteomic signatures from HBV‐HCC by chitosan‐magnetic bead‐based separation and DIA‐proteomic analysis;Journal of Extracellular Vesicles;2024-08-29

3. Multimodal imaging-based prediction of recurrence for unresectable HCC after downstage and resection-cohort study;International Journal of Surgery;2024-06-04

4. Alarmin S100A8 imparts chemoresistance of esophageal cancer by reprogramming cancer-associated fibroblasts;Cell Reports Medicine;2024-06

5. Involvement of lncRNAs in the regulation of aerobic glycolysis in hepatocellular carcinoma: Main functions, regulatory mechanisms and potential therapeutic implications (Review);Oncology Reports;2024-04-25